In Brief Zampieri et al. monitor short-term metabolic changes in Escherichia coli after exposure to antibiotics. A core set of metabolites exhibits a unique rapid response to antibiotic with common or radically different modes of action. By interfering with such cellular response, the authors reveal the functional role of metabolism in mediating the first immediate response to antibiotics.
INTRODUCTION
Novel antibacterial tactics are required to combat the rise of antibiotic resistance. Classical discovery approaches, such as target-and cell-based screens, that seek single targets or individual bioactive compounds have been shown to be mostly inadequate for the identification of novel antibacterial agents that can effectively penetrate and kill the bacteria in vivo (Brown and Wright, 2016; Pethe et al., 2010) . To cope with emerging resistance and lack of newly developed drugs, research has focused on vulnerabilities in the bacterial response to antibiotic treatments (Bollenbach et al., 2009; Davies et al., 2009; Kohanski et al., 2007; Brynildsen et al., 2013; Lobritz et al., 2015; Nandakumar et al., 2014) . Any bacterium surviving the first exposure to an antibiotic agent represents a threat, because it increases the risk for the rise of resistant populations (Fridman et al., 2014) . Hence, systematic analysis to improve our understanding of the immediate microbial response to antibiotic exposure holds the promise to discover new routes to fight the early onset of antibacterial resistance development.
Metabolism plays a central role in mediating rapid adaptation to unexpected environmental changes, such as stresses (Yan and Shi, 2007; Xiao et al., 2012; Lima et al., 2013; Link et al., 2015) or nutrient shifts (Link et al., 2013; Xu et al., 2012) . Metabolites can act as global regulators and mediate protein regulation via rapid allosteric binding (Link et al., 2013; Doucette et al., 2011) , through transcriptional regulation (Novick and Weiner, 1957; You et al., 2013) , or by functioning as signaling molecules at the population level (Lee et al., 2010) . Although most antibiotics do not directly target metabolism, several evolutionary traits in resistant bacteria are closely associated with metabolic functions, such as glycolysis (dos Santos et al., 2010) , amino acid biosynthesis (Lee et al., 2010) , respiration, and energy metabolism (Hammer et al., 2014) . Although metabolic traits of resistant bacteria may mainly account for compensatory mutations, several lines of evidence advocate a more direct role of metabolism in mediating the early response to antibiotics. Stringent response (Nguyen et al., 2011) , cellular respiration (Nandakumar et al., 2014; Moritz et al., 2010) , carbon catabolism (Linares et al., 2010; Hoffman et al., 2010) , iron homeostasis (Davies et al., 2009) , biosynthesis of triglyceride (Baek et al., 2011) , redox balance (Brynildsen et al., 2013) , nitrogen metabolism, and ATP production (Kohanski et al., 2008; Bernier et al., 2011; Thatcher and Roberts, 1961; Girgis et al., 2009; Li and Zhang, 2007; Schurek et al., 2008) were all shown to participate in antibiotic tolerance and, at the same time, contribute to the emergence of multidrug resistance (Kohanski et al., 2010) . While numerous high-throughput studies have been performed to elucidate the antibiotics' mechanisms of action, such as cytological profiling (Vincent et al., 2016) , genetic screens (Nichols et al., 2011; Zlitni et al., 2013) , or gene expression and proteomic profiling (Kohanski et al., 2007) , direct experimental evidence that rapid metabolic changes can be causal in mediating the bacterial response to antibiotics is largely missing Belenky et al., 2015; Vincent et al., 2016; Hoerr et al., 2016) .
Here we used nontargeted metabolomics to quantify the short-term metabolic response to widely used antibiotics (Figure 1) . To identify immediate metabolic changes, we monitored the levels of $750 intracellular metabolites in Escherichia coli from 1 min to 1 hr after antibiotic exposure. Although most metabolic changes were drug and dosage specific, a small number of metabolites showed similar dynamics across antibiotics with different modes of action, irrespective of drug dosage, suggesting common metabolic responses and drug side effects. Moreover, the time-dependent sequence of metabolic events during the immediate bacterial response to antibiotics revealed potential weaknesses in the ability to transiently tolerate antibiotic therapies. The dynamic metabolic responses provided unprecedented insights into the early bacterial response to existing antimicrobial compounds. Finally, we demonstrate that bacterial Visualization of the high-dimensional metabolic data by a multidimensional scaling approach (e.g., mdscale MATLAB function) (Seber, 1984) . The 2D map visualizes the pairwise similarity between changes induced by the different antibiotic treatments. The 324 putatively annotated metabolite changes across all 20 conditions of Figure S1 are projected in a lower-dimensional 2D map, where each dot or triangle represents the metabolome changes associated to different conditions 1 hr after the perturbation. Antibiotics, and corresponding abbreviations, used in this study, their tested concentrations, and the mechanism of action are reported in the figure legend.
tolerance to antibiotics can be altered by interfering with such an immediate cellular response. This represents an attractive complementation to the discovery of new antibiotic agents and hence has the potential to alleviate the escalating emergence of bacterial resistance.
RESULTS

Timing and Origin of the Metabolic Changes in Response to Antibiotics
To characterize the immediate metabolic response to antibiotics, we exposed exponentially growing E. coli cultures in complex media to nine antibiotics that represent five mechanisms of actions: inhibition of cell wall synthesis (amoxicillin and ampicillin), protein synthesis by targeting either the 50S (chloramphenicol) or the 30S ribosomal subunits (spectinomycin and kanamycin), DNA gyrase (nalidixic acid and norfloxacin), and folate synthesis (trimethoprim and sulfamethizole). As controls, we monitored mocktreated cultures perturbed with pure medium and cultures challenged with hydrogen peroxide. This latter condition was applied to elicit a stereotypical metabolic response to oxidative stress, previously associated with a generic response to antibiotic exposure (Kohanski et al., 2007) . For each drug, we selected two dosages: one close to the concentration that inhibits growth by 50% and a higher dosage close to the minimum inhibitory concentration (MIC) (Figure 1 ). Culture broth samples were filtered and the intracellular metabolome was extracted with hot ethanol 1, 5, 10, 15, 30, 40, 50 , and 60 min after drug exposure. Samples were analyzed by time-of-flight mass spectrometry (Fuhrer et al., 2011) , resulting in the detection of 13,311 ions, of which 3,029 (including salt adducts and neutral losses) could be putatively annotated to 784 metabolites in a genome-scale model of E. coli metabolism (Table S1 ) (Orth et al., 2011) .
We systematically evaluated the impact of every treatment using a statistical approach that defines the significance of each metabolite response upon perturbation. We first interpolated the metabolome profiles using an adaptive regression spline scheme (Friedman and Roosen, 1995) . Responding metabolites were identified with a permutation test that quantifies the reliability of changes in terms of p values, and we focused on metabolites with a p value % 0.05 and an absolute log 2 fold change of at least 1, relative to the concentration before treatment. A systematic comparative analysis with mock-treated cells was performed to remove changes caused by artifacts of residual media components, not by the drug treatment.
Disentangling indirect growth-related responses from metabolic responses that are directly linked to the antibiotic mode of action is crucial for data interpretation. To avoid considering indirect growth inhibition effects, we compared metabolic changes induced by low and high dosages of the same antibiotic. For each metabolite, we computed the similarity between dynamic changes and restricted our analysis to 324 annotated metabolites with similar dynamic responses at different drug concentrations and hence at different growth reductions ( Figures  1, S1 , and S2). This procedure, although stringent, selects only responsive metabolites that exhibit a consistent and reproducible response irrespective of antibiotic dosage and growth inhibition. A multidimensional scaling approach (Seber, 1984) was used to project the high-dimensional antibiotic-perturbed metabolome profiles in a reduced two-dimensional (2D) space (Figure 1 ). The 324 metabolites exhibiting a similar dynamic response at different dosages of at least one antibiotic were used to compute Spearman pairwise similarities across the antibiotic perturbations, and overall similarities were reproduced on the 2D map. The more distant two points are on the map, the more dissimilar are the metabolome responses elicited by the different antibiotics and dosages. Consistent with previous studies , antibiotic treatment has widespread effects on microbial metabolism ( Figure S1 ; Table S1 ). By visualizing the similarity between metabolome changes induced by the different antibiotic treatments, we revealed common patterns among folate inhibitors or gyrase inhibitors and highly drug-specific rapid metabolic changes among protein and cell wall biosynthesis inhibitors ( Figure S2 ).
Overall, intermediates of nucleotide and amino acid biosynthesis were the most recurrently affected metabolites among the different drug treatments ( Figures S1 and S2 ). This observation is in agreement with a similar dynamic analysis showing increasing concentrations of nucleotide precursors upon antibiotic exposure. Moreover, E. coli knockout mutants of enzymes in nucleotide metabolism are more sensitive to the tested antibiotics and tend to exhibit severe aggravating effects (i.e., negative epistasis) ( Figure S3 ) (Nichols et al., 2011) , suggesting a more direct association of this pathway to a general antibiotic-stress response . This observation is consistent with previous studies reporting gene expression changes in nucleotide biosynthesis to be one of the most pronounced transcriptional responses upon different stress conditions (Gasch et al., 2000; Jozefczuk et al., 2010) . In our data, intermediates of purine and pyrimidine biosynthesis were not only the most common affected metabolites upon antibiotic treatments but also the most readily responding ones ( Figure S3 ). This reinforces the potential role for nucleotide metabolism in triggering an early common stress response (Foti et al., 2012) and suggests that changes in the pathway are not simply an indirect consequence of growth inhibition.
On average, a quarter of responsive metabolites reached half of their maximum change (e.g., time to half-peak [THP]) (Chechik et al., 2008) less than 5 min after drug exposure ( Figure S4 ). These immediate effects are unlikely to be mediated by transcriptional adaptation and are more amenable to intuitive interpretation. For instance, most of the immediate responsive metabolites to trimethoprim can be directly linked to its action on folate biosynthesis, such as the tetrahydrofolate accumulation ( Figure S5 ) (Kwon et al., 2008) . Moreover, those metabolites undergoing abrupt changes upon trimethoprim treatment are substrates or products of enzymatic reactions that require reduced folate cofactors (e.g., deoxyuridine monophosphate [dUMP] ), are in their immediate vicinity (e.g., 5
0 -phosphoribosylglycinamide), or tend to cluster in metabolic pathways where folate cofactors are needed, such as pantothenate, methionine, thymidine, and purine biosynthesis ( Figure S5 ).
To better understand the function of metabolic changes in response and adaptation to antibiotics with nonmetabolic targets (e.g., ribosomes or gyrase), we identified metabolites that exhibited similar dynamic responses across different perturbations. This selective criterion resulted in 37 responsive metabolites exhibiting similar metabolic patterns between at least two treatments (Figures 2 and S1 ), indicating either mode of actionspecific metabolic changes or potential common responses across antibiotics with different mechanisms of action. None of the selected metabolites exhibited similar pattern in all treatments, further excluding the possibility that these metabolites respond to growth inhibition. Therefore, we here focused exclusively on those changes for which we can exclude indirect growth-related effects. Overall, the commonality among metabolic responses induced by different antibiotics is lower than previously observed . This might be due to delineating and excluding from our approach general growth inhibition from direct antibiotic effects. Nevertheless, consistent with previous data , dynamic patterns of selective metabolites were similar between antibiotic-and hydrogen peroxide-treated cells (Figure 2 ), suggesting common metabolic propagation of perturbations inhibiting essential cellular processes, such as protein synthesis, DNA replication, cell wall biosynthesis, and oxidative stress, in agreement with previous experimental evidence (Zhao and Drlica, 2014; Kohanski et al., 2007) .
With the exception of amoxicillin and ampicillin, antibiotics sharing a similar mechanism of action have at least one exclusive responsive metabolite in common that exhibits a different response in all other tested treatments (Figures 2 and S1). Consistent with our previous observations, common dynamic changes induced by the two folate inhibitors (blue metabolites in Figure 2 ) were mostly related to inhibition of folate biosynthesis and the deficit of folate cofactors for the synthesis of amino acids, such as methionine. Half of the common metabolites between the two quinolone antibiotics (red metabolites in Figure 2) were related to nucleotide and nucleotide sugars, suggesting a potential link between gyrase inhibition and activated nucleotide sugars. In contrast, rapid changes induced by protein synthesis and cell wall inhibitors were more heterogeneous; in particular, chloramphenicol exhibited several metabolic changes in common with hydrogen peroxide (Figure 1 ). Some of these metabolites, such as acetyl-coenzyme A (CoA) and oxidized glutathione, have antioxidant properties (Masip et al., 2006) , while others, such as N-acetyl-glutamate, have never been implicated in oxidative stress response. In the following, we investigate the roles of (1) N-acetyl-glutamate, as an emblematic example of a common metabolic response between protein synthesis inhibitor and oxidative stress, linking the action of chloramphenicol to that of hydrogen peroxide; (2) deoxythymidine 5 0 -diphosphate (dTDP)-rhamnose, exhibiting a unique response upon exposure to quinolone antibiotics; and (3) a less obvious metabolic adaptation to trimethoprim and sulfamethizole treatments, involving nucleotide biosynthesis. An Unexpected Role for Ammonia in Mediating Chloramphenicol Toxicity Short-term accumulation of N-acetylglutamate was observed in complex medium-grown cells upon chloramphenicol or hydrogen peroxide challenge (Figure 3A) . This metabolite is the first intermediate in arginine biosynthesis, and its production in E. coli is allosterically inhibited by the end product arginine. In higher cells, N-acetyl-glutamate is a key allosteric regulator of the urea cycle and plays a crucial role in detoxification from hyperammonemia (Caldovic and Tuchman, 2003) . Similar to mammals, in the absence of external arginine, we found steady-state levels of N-acetyl-glutamate in E. coli to scale proportionally with NH 4 + concentrations in the media ( Figure S6 ). We hypothesized that N-acetyl-glutamate accumulation is not a mere indirect effect of stalled protein biosynthesis but rather that arginine biosynthesis plays an active part in the response to chloramphenicol. To test this hypothesis, we monitored the dynamics of N-acetyl-glutamate upon chloramphenicol treatment in cells grown in the presence or absence of arginine and with different concentrations of ammonia to alter the basal levels of N-acetylglutamate. In the absence of external arginine, when arginine biosynthesis occurs, N-acetyl-glutamate levels dropped immediately after chloramphenicol exposure. This drop was more pronounced when the ammonia concentration in the medium was increased 20-fold to 200 mM ( Figure 3B ). As expected (Link et al., 2015) , independent of the ammonia concentration, most amino acids accumulate intracellularly upon exposure to chloramphenicol ( Figure S7 ). However, arginine ( Figure 3C ) and threonine ( Figure S7 ) exhibited different dynamics in response to chloramphenicol exposure in culture media with either low or high ammonia concentration ( Figures 3C and S7 ). Arginine rapidly accumulated in the medium supplemented with 200 mM of ammonia ( Figure 3C ). The rapid accumulation of arginine and consumption of its precursor N-acetyl-glutamate, in the absence of supplemented amino acids, suggested that chloramphenicol actively induces arginine biosynthesis and that its response depends on the ammonia concentration in the media. (E) Intracellular ROS concentrations (dihydroethidium assay) (Klinger et al., 2010) up to 2 hr after chloramphenicol exposure of cells grown in M9 glucose with 10 mM NH 4 + (brown) and 200 mM NH 4 + (green). This is reinforcing our intuition that accumulation of N-acetylglutamate in complex medium is not simply an indirect effect of downstream bottlenecks caused by an impaired protein biosynthesis. Intriguingly, higher levels of ammonia aggravate the toxicity of chloramphenicol. The MIC was 4-fold lower at 200 mM compared to 10 mM NH 4 ( Figure 3D ). Altogether, our results pointed to an unexpected functional interplay between ammonia metabolism and chloramphenicol's mode of action. Because E. coli can tolerate high concentrations of ammonia ( Figure S6 ) (M€ uller et al., 2006) , we sought potential explanations for the increased chloramphenicol toxicity in our metabolome data. The imbalance of reduced and oxidized glutathione in response to chloramphenicol and high ammonia concentration ( Figure 3C) , together with the similar response of N-acetyl-glutamate to hydrogen peroxide treatment ( Figure 3A) , suggested oxidative stress to be a possible cause for ammonia-dependent chloramphenicol sensitivity (Kanai et al., 2006) . To test this hypothesis, we measured reactive oxygen species (ROS) concentrations in cells perturbed with chloramphenicol at low and high ammonia and found modest but significantly (p value % 0.01) increased ROS levels at 200 mM ammonia ( Figure 3E ). We concluded that by interfering with ammonia metabolism, normal counteractive mechanisms for combating oxidative stress are not sufficient; therefore, ROS levels increase (Figure 3E ). Overall our results suggest that chloramphenicol impinges on ammonia metabolism and induces an active response of arginine biosynthesis, similar to hydrogen peroxide. In light of this result, we speculate that increased arginine biosynthesis upon protein synthesis inhibition might be an adaptive mechanism that promotes the production of polyamines, such as putrescine or spermidine, to compensate for generation of ROS, consistent with previous observations (Tkachenko et al., 2012) .
In a large metabolomics compendium of 3,807 E. coli gene deletion mutants (Fuhrer et al., 2017) , we found significant accumulation or depletion of N-acetyl-glutamate in mutants of nitrogen assimilation (e.g., DrpoN and DglnD; p value, 8.4eÀ3) or respiration (e.g., DacnB, DgltA, DsdhA, DshdB, and DsdhD; p value, 2.6eÀ6), suggesting that imbalanced citric acid cycle activity can induce a similar response (Brynildsen et al., 2013) . Although ammonia is not toxic for E. coli (M€ uller et al., 2006) , we found that high concentrations of ammonia render chloramphenicol more effective and cause radically different response in the production and secretion of certain amino acids. In particular, secretion of the branched chain amino acids, leucine or iso-leucine and valine, is markedly higher when ammonia is present in the media ( Figure S8 ). Amino acid secretion has been previously shown to be a rudimental mechanism for ammonia detoxification in yeast (Hess et al., 2006; Reisser et al., 2013) , and branched chain amino acids have attracted particular interest, because they are believed to support ammonia detoxification in muscle (Dam et al., 2013) . While the exact mechanisms by which ammonia amplifies the toxicity of chloramphenicol remain to be elucidated, our results revealed a side effect of protein synthesis inhibition affecting ammonia metabolism and, in the presence of elevated level of ammonia, resulting in oxidative stress. Amino acid metabolism seems to play an active role in counteracting an excess of unused ammonia (i.e., NH 4 + /NH 3 ). This excess of ammonia, in turn, seems to cause increased oxidative stress under chloramphenicol treatment, possibly by affecting tricarboxylic acid (TCA) cycle activity.
dTDP-Rhamnose Mediates Transcriptional Regulation of gyrA Norfloxacin and nalidixic acid induced overall similar metabolic changes, which differ from most other tested perturbing agents (Figures 1 and S2) . The nucleotide sugar dTDP-rhamnose undergoes the most rapid and largest changes among the six metabolites that exhibit a similar response exclusive to the gyraseinhibiting quinolones nalidixic acid and norfloxacin ( Figure 4A ). The identity of dTDP-rhamnose was confirmed by comparison to standards with liquid chromatography coupled to tandem mass spectrometry ( Figure S9 ) (Buescher et al., 2010) , and its accumulation was reproduced across different cultivation conditions and exposure to another quinolone antibiotic (i.e., ofloxacin) ( Figure 4C ). In general, dTDP-rhamnose is an activated precursor metabolite that transfers the rhamnose moiety to capsular polysaccharides. Its biosynthesis consists of four enzymatic steps starting from glucose-1-phosphate ( Figure 4B ). Under standard laboratory conditions, disruption of the biosynthetic pathway does not lead to any growth phenotype in E. coli, but dTDP-rhamnose biosynthesis is essential in mycobacteria (Ma et al., 2002) . Given the essential role of dTDP-rhamnose biosynthesis in mycobacteria, we wondered whether similar metabolic changes are induced in mycobacteria upon exposure to norfloxacin, presently used to treat tuberculosis in cases involving resistance or intolerance to first-line antituberculosis therapy. We found the metabolic response to norfloxacin to be partially conserved in Mycobacterium smegmatis, a nonpathogenic model strain ( Figure 4D ). Different from E. coli, in which dTDP-rhamnose exhibited the largest change upon norfloxacin treatment, the most considerable affected metabolite in M. smegmatis was cyclic AMP (cAMP). Although slower, dTDPrhamnose also exhibited marked accumulation in M. smegmatis (top 20 affected metabolites), hinting at a more general and conserved role for dTDP-rhamnose in the metabolic response to gyrase inhibition (Table S1) .
We next asked whether accumulation of dTDP-rhamnose has a direct functional role in mediating tolerance to quinolone antibiotics. To this end, we aimed at modulating intracellular dTDP-rhamnose levels by deleting or overexpressing genes encoding for biosynthetic enzymes in E. coli ( Figures 4A and 4B) . dTDP-rhamnose concentrations were 2-to 3-fold lower upon deletion of rfbC or rfbD genes ( Figure 5A ) and 2-fold higher upon their overexpression ( Figure 5B) . A drastic reduction of dTDP-rhamnose concentration was obtained upon pgm deletion, suggesting that complete inhibition of dTDP-rhamnose production could be achieved only by inactivating the upstream precursor formation glucose-1-phosphate ( Figure 5A ). By testing the sensitivity of these E. coli mutant strains to both quinolone antibiotics, we found that intracellular dTDP-rhamnose concentration correlated with the MIC of nalidixic acid and norfloxacin, although changes in MIC were mild ( Figure 5C ).
Two putative mechanisms could explain a direct role for dTDP-rhamnose biosynthesis in mediating tolerance to gyrase inhibition: (1) dTDP-rhamnose physically interacts with the gyrase complex, protecting it from quinolone action (e.g., competitive binding), or (2) dTDP-rhamnose mediates protein synthesis of the antibiotic target, the GyrA subunit, which, in turn, can alter the tolerance to quinolones (Neumann and Qui-ñ ones, 1997; Anderle et al., 2008; Franco and Drlica, 1989) . By incubating the purified E. coli gyrase complex with the dTDPrhamnose and norfloxacin in vitro, we could not detect enhanced in vitro activity of the complex or a reduced inhibitory effect of the antibiotic ( Figure S10 ). This experiment indicates that dTDPrhamnose does not bind directly to the gyrase complex. To test a potential alternative role for dTDPrhamnose in regulating the dynamic response of GyrA protein synthesis, we used a luciferase reporter fused to the gyrA promoter and monitored its transcription in wild-type (Anderle et al., 2008) , Dpgm, or DrfbC mutants upon exposure to norfloxacin ( Figure 5D ). Consistent with previous studies monitoring either gyrase protein abundance directly (Aedo and Tse-Dinh, 2012) , or transcript abundance (Neumann and Qui-ñ ones, 1997; Anderle et al., 2008; Franco and Drlica, 1989) , a transient overshoot of gyrA expression was observed in wildtype E. coli immediately after norfloxacin treatment ( Figure 5D ) (Menzel and Gellert, 1983) . A similar response was observed in the DrfbC strain, though the initial peak in expression was almost halved ( Figure 5D ). The gyrA transcriptional response was abolished in the Pgm-deficient strain that showed very low dTDP-rhamnose concentration ( Figure 5D ). Thus, increasing concentrations of dTDP-rhamnose appear to cause increased transcription of gyrA upon quinolone antibiotics. While the overexpression of the gyrase complex can be toxic to cells (Palmer and Kishony, 2014) , overexpressing the GyrA subunit is an intrinsic response of E. coli to gyrase inhibitors like norfloxacin (Neumann and Quiñ ones, 1997; Anderle et al., 2008) and potentially helps cells to cope with the antibiotic by sequestering the antibiotic and thereby reducing the number of drug-stabilized DNA-gyrase complexes, which cause the toxic double-stranded DNA breaks possibly responsible for cell death.
How can dTDP-rhamnose respond to GyrA activity and in turn regulate its transcription? In principle, any gene affecting the intracellular abundance of dTDP-rhamnose could be a potential regulator of gyrase transcription. To identify candidate regulators, we queried a large compendium of metabolome profiles in all E. coli deletion mutants for gene knockouts that affect dTDP-rhamnose abundance (Fuhrer et al., 2017) . Unexpectedly, we found the DarcA, DarcB, and DgltA strains to exhibit the largest accumulation of dTDP-rhamnose among the 3,807 metabolically characterized mutants ( Figure S10 ) (Fuhrer et al., 2017) . ArcB responds to the redox state of the cellular quinone pool and regulates the activity of the transcription factor ArcA via phosphorylation, while GltA encodes for the citrate synthase enzyme. The two-component regulatory system ArcAB regulates a large portion of genes involved in cellular respiration, among them gltA (Liu and De Wulf, 2004; Perrenoud and Sauer, 2005) . Contrary to our previous observations of increased resistance in strains with high dTDP-rhamnose concentration, we found that (1) despite higher dTDP-rhamnose levels ( Figure 6A ), DarcA was more sensitive to norfloxacin and nalidixic acid ( Figure 6B ), (2) overexpression of ArcA (ArcA (+) ) resulted in slightly higher
MICs for norfloxacin and nalidixic acid ( Figure 6B ) while having almost 4-fold lower levels of dTDP-rhamnose, and (3) metabolic changes induced upon overexpression of ArcA were more similar to those observed in gyrA (+) ( Figure 6C ). Hence, we hypothesized gyrA is also transcriptionally regulated by ArcA. To test this hypothesis, we monitored gyrA expression upon expression control of arcA by an isopropyl b-D-1-thiogalactopyranoside (IPTG)-inducible promoter. In agreement with our hypothesis, we observed marked upregulation of gyrA transcription upon induction of arcA ( Figure S11 ). While deletion of arcA is not sufficient to abolish the rapid gyrA overexpression observed in cells perturbed with norfloxacin ( Figure S11 ), we found a new link that potentially enables gyrase transcription to rapidly sense and adapt to environmental cues and interfere with cell metabolic activity. In both overexpression strains, gyrA (+) and arcA (+) , we observed a marked reduction of dTDP-rhamnose (nearly four times lower) and a parallel accumulation of the upstream dTDP-glucose ( Figures 6A-6C ) identical to the deletion of rfbC or rfbD ( Figure 5A ). Moreover, we found that overexpressing gyrA in a DarcA mutant (DarcA + gyrA (+) ) could rescue the , and pgm (+) mutants relative to wild-type E. coli.
(D) GyrA promoter activity in E. coli wild-type and DrfbC and Dpgm mutants. GyrA promoter activity is monitored via a reporter gene that used fusions of the luxCDABE operon to the gyrA promoter (Anderle et al., 2008) . Luminescence readouts normalized by the corresponding optical density is reported during normal growth (blue) and when exposed to 80 ng/mL norfloxacin (red). Data are mean ± SD of three biological replicates. observed metabolic phenotype ( Figure 6A ). The preceding identified effects of ArcA and GyrA overexpression and impaired dTDP-rhamnose biosynthesis fit together into a new genetic circuit in which GyrA abundance or activity feeds back into dTDPrhamnose biosynthesis, which can in turn regulate gyrA transcription to maintain homeostasis. In bacteria, genetic circuits in which gene transcription is under the control of a metabolite form a common strategy to enable rapid and robust adaptation to fluctuating environmental conditions (You et al., 2013; Novick and Weiner, 1957) . The genetic circuit identified here links DNA replication to metabolism, in particular the redox state of the cellular quinone pool and cellular respiration (e.g., ArcA and GltA), via a feedforward and feedback loop: while increased production of dTDP-rhamnose enables an immediate overexpression of GyrA upon exposure to gyrase inhibitors (feedforward activation), higher levels of GyrA further inhibit dTDP-rhamnose production (feedback inhibition) ( Figure 6D ).
Differential Response to Folate Inhibitors
So far, we have focused on metabolic commonalities that revealed similarities in the mode of action and adaptation to different antibiotics. Next, we look at an example of how metabolic differences between the responses to antibiotics with a similar mode of action, such as trimethoprim and sulfamethizole, can reveal important aspects of how a perturbation propagates from the target to the whole metabolic network. Trimethoprim and sulfamethizole prevent folate biosynthesis by inhibiting the synthesis of tetrahydrofolate and dihydrofolate, respectively. Although metabolic changes induced by trimethoprim are more (C) Growth rate inhibition upon individual treatments of E. coli wild-type, DpurN, and DpurT with 75 ng/mL trimethoprim (blue), 2 mg/mL sulfamethizole (light blue), and both simultaneously (brown) relative to unchallenged wild-type E. coli. A multiplicative epistatic model (Segrè et al., 2005) was used to established the expected inhibition of the two drugs when used in combination (yellow). Data are mean ± SD of three biological replicates. similar to those elicited by sulfamethizole than those elicited by any other antibiotics (Figure 1 ), we observed some unexpected differences between the dynamics of metabolite changes in response to these two folate synthesis inhibitors. Specifically, intermediates in the 5-aminoimidazole ribonucleotide biosynthesis exhibited radically different patterns. Trimethoprim treatment, but not sulfamethizole treatment, caused a rapid accumulation of the substrate and precursors of phosphoribosylglycinamide formyltransferase (i.e., 5 0 -phosphoribosylamine and 5 0 -phosphoribosylglycinamide) and a parallel rapid depletion of 5 0 -phosphoribosyl-N-formylglycinamide ( Figures 7A and 7B ). These metabolic patterns reflect the immediate shortage of 10-formyltetrahydrofolate and/or formate, the two cofactors used by PurN and PurT to catalyze the formation of 5 0 -phosphoribosyl-N-formylglycinamide.
We hypothesized that the unexpected differences in 5-aminoimidazole ribonucleotide biosynthesis could be ascribed to the difference between the enzymatic steps targeted by trimethoprim (e.g., noncompetitive inhibition of FolA) and those targeted by sulfamethizole (e.g., competitive inhibition of FolP). Furthermore, the diverse metabolic changes might reflect subtle key differences in the way the two antibiotics limit cell growth and can help us to understand the underlying mechanism by which the two drugs, when used in combination, yield synergistic interaction (Nichols et al., 2011) . To test this hypothesis, we deleted purT and purN individually and found that (1) purN deletion aggravates the effect of trimethoprim, while the inhibitory efficacy of sulfamethizole remains unaffected; (2) purT deletion increased resistance to sulfamethizole, while no changes were observed upon trimethoprim treatment; and (3) the deletion of purN abolished the synergistic interaction between trimethoprim and sulfamethizole, while deletion of purT made it stronger ( Figures  7C and S12) . Thus, the PurN-catalyzed reaction seems to be part of or interfere with the underlying mechanism by which sulfamethizole and trimethoprim interact synergistically.
We hypothesize that recycling of 10-formyltetrahydrofolate via PurN could be crucial for replenishing the tetrahydrofolate pool when cells are exposed to trimethoprim, while recycling of 5,10-methylenetetrahydrofolate in dihydrofolate by thymidylate synthase ( Figure S5 ) could serve a similar purpose and replenish the dihydrofolate pool when cells are exposed to sulfamethizole ( Figure S12 ). Hence, we speculate that the difference in an immediate shortage of different folate cofactors between trimethoprim and sulfamethizole could be the basis of their synergistic interaction (Nichols et al., 2011; Kwon et al., 2008 ). This in turn can be the result of complex allosteric regulation mediated by dihydrofolate and/or tetrahydrofolate on the downstream enzymatic reactions (Kwon et al., 2008) .
DISCUSSION
Little is known about the downstream metabolic changes induced by antimicrobial agents. Exploring the dynamics of short-term adaptive metabolic changes to antibiotic exposure revealed a time-dependent sequence of events that contribute to cell death or escape through antibiotic stress responses. Overall, the early biochemical processes involved in sensing and deploying the first line of defense may be subject to intervention and eventually reduce the number of surviving bacteria to the initial antibiotic exposure.
Similar to previous studies, we found drug-specific (Hoerr et al., 2016; Vincent et al., 2016) and common metabolic changes across antibiotics with different mechanisms of action . Unlike Vincent et al. (2016) , we also observed discernible metabolic changes when targeting nonmetabolic processes, such as DNA replication or ribosome biosynthesis. Although several of the rapid metabolic changes cannot be intuitively interpreted and related to the antibiotic mechanisms of action, we here demonstrated that metabolism can play a direct role in mediating the first adaptive response to an antibiotic agent.
Keys to the interpretation of antibiotic-induced metabolic changes were (1) to filter out metabolic changes likely caused by an indirect effect of growth inhibition, (2) to compare metabolic changes across multiple perturbations to discriminate metabolic phenotypes that are exclusive for antibiotic modes of action, and (3) to link the action of external perturbations (e.g., antibiotics) to that of genetic perturbations (e.g., gene deletions). This strategy was systematically applied to better understand the functional role of different metabolic pathways, such as arginine, dTDP-rhamnose, and nucleotide biosynthesis, in mediating the response to protein synthesis, gyrase, and folate inhibitors. Selection of ''direct'' metabolic effects is a major challenge in the analysis and interpretation of dynamic metabolome adaptive changes in response to an antibiotic. Here we applied a selective criterion that only selects metabolites exhibiting qualitatively similar responses at low and high dosages of at least one antibiotic. These metabolites represent a core set of responsive changes that are robust and reproducible upon changes of drug dosage or inhibitory activity. However, future in-depth analysis of growth-dependent metabolic changes, by profiling a larger set of drug dosages, could shed lights on potential common routes by which growth is inhibited or cells are killed by different antibiotics.
In the case of quinolones antibiotics, we demonstrated that inhibition of gyrase promotes rapid gyrA upregulation via a feedback loop, leading to the immediate accumulation of dTDP-rhamnose. Mutations in pgm and rfbC have been previously associated with DNA supercoiling (Hardy and Cozzarelli, 2005) and tolerance to DNA damage (Han et al., 2010) ; however, the underlying mechanisms remained unknown. Here we showed that pgm is essential for the prompt transcriptional regulation of gyrA. While it has been shown that overexpression of the gyrase complex is toxic and has a detrimental effect on tolerance to ciprofloxacin, an analog of norfloxacin (Palmer and Kishony, 2014) , we here tested the effect of overexpressing the antibiotic-target GyrA subunit. The gyrA promoter-inducing activity of norfloxacin has been shown to correlate with its inhibitory activity in vitro and was used as an effective reporter to predict compound modes of action (Anderle et al., 2008) . Overexpressing the GyrA subunit alone might sequester the antibiotic and reduce the number of drug-stabilized DNA-gyrase complexes, which can cause toxic double-stranded DNA breaks. Further studies are necessary to investigate and unravel the potential role for the GyrB subunit in mediating the response to gyrase inhibitors.
It is known that the phosphorylation potential of a cell is coupled to gyrase activity (van Workum et al., 1996) , and the first evidence of a link between metabolic processes and DNA gyrase was observed in Rhodobacter capsulatus and involves photosynthetic genes (Zhu and Hearst, 1988) . In E. coli, we employed dTDP-rhamnose levels as an indicator for gyrase activity to find that gyrA expression is induced upon overexpression of a global respiratory metabolic transcription factor ArcA. This finding revealed how cells can potentially coordinate DNA replication processes with changes in metabolic states, such as respirofermentative activity.
Overall, we found several metabolites featuring similar patterns between different antibiotic treatments and hydrogen peroxide (Figure 2 ). We don't expect the metabolic response to antibiotics to resemble that of cells perturbed with hydrogen peroxide. However, the striking similarity of some metabolic changes induced by antibiotics with hydrogen peroxide suggests diverse and drug-specific mechanisms by which antibiotics elicit a similar response to oxidative stress or can interfere with production of ROS. We followed up on the specific response of N-acetyl-glutamate to chloramphenicol. N-acetylglutamate accumulation was observed in other antibiotics, such as kanamycin and spectinomycin, but only at higher dosages ( Figure 3A) , suggesting that this metabolic feature might be a hallmark of protein synthesis inhibition and not confined to chloramphenicol (Figure 2A ). Kanamycin and spectinomycin induced largely different metabolic responses at low and high dosages (Figure 1 ). This might suggest that indirect toxic effects of antibiotics could be observed only above a certain growth inhibitory dosage. Moreover, similar to hydrogen peroxidetreated cells, ATP levels are increased upon treatment with a high dosage of chloramphenicol, spectinomycin, and norfloxacin. These observations also raised the need in future studies to investigate the long-term metabolic changes induced by antibiotics and the indirect role of growth inhibition in affecting metabolic pathways. Overall, we observed for the first time in E. coli a toxic role for ammonia in combination with chloramphenicol action. Collective evidence relates unbalanced ammonia metabolism to generation of ROS. At relatively low ammonia concentrations, cells can neutralize ROS, but higher concentrations aggravate ROS production and increase chloramphenicol toxicity. Although it is not clear which reactions could be affected by higher ammonia concentrations and are thereby responsible for increased ROS production, the link between gene deletions in the TCA cycle and N-acetyl-glutamate levels suggests altered TCA activity to be the basis of ammonia-dependent toxicity upon chloramphenicol treatment. Alternative strategies to directly interfere with bacterial ammonia metabolism should be further investigated to potentially increase the efficacy of protein synthesis inhibitors in a clinical setting. While oxidative stress was described as a general side effect of bactericidal antibiotics (Brynildsen et al., 2013) , we here observed a condition-dependent oxidative stress response for a bacteriostatic antibiotic, such as chloramphenicol.
The action of a drug cannot be described in terms of a single static target; rather, the entire induced response chain must be considered. A single chemical species could have multiple direct and indirect targets (Kwon et al., 2008) , simultaneously interfering with many pathways, enzymes, and metabolites. To deal with such complexity, methods capable of monitoring the cellular response to an external perturbing agent on a genome scale and in a time-dependent manner become crucial. Untargeted metabolome analysis to resolve the early response of E. coli to antibiotics is complementary to systematic highthroughput platforms used to monitor drug-induced transcriptional responses (Kohanski et al., 2007; Gardner et al., 2003; Iorio et al., 2010) or growth phenotypic and cytological assays (Sundaramurthy et al., 2014; Woehrmann et al., 2013; Chevereau and Bollenbach, 2015; Woo et al., 2015; Nichols et al., 2011; Soo et al., 2011; Zlitni et al., 2013; Nonejuie et al., 2013 ). Here we demonstrated that by monitoring the metabolome during the first exposure to different antibiotics, we could identify pathways and biological processes contributing to the global cell response to antibiotic treatments. The presented approach is broadly applicable to other organisms, other perturbations, and more realistic clinical settings. Enlarging the space of chemicals or concentrations and including more clinically relevant conditions could reveal unexpected metabolic adaptive mechanisms that counteract the action of antibiotics, such as those described in this study. Finding new ways to interfere with such metabolic strategies could offer new alternative targets for treatment of bacterial infection. Moreover, dynamic metabolome changes could be potentially used as fingerprint markers for the inference of the mechanism of action of antimicrobial compounds with unknown mechanisms of action, holding promise for advancing pharmacology beyond antibiotic discovery. 
Nontargeted Metabolomic Profiling
The analysis was performed on an Agilent 6520 Series quadrupole time-offlight mass spectrometer (Agilent), as described previously (Fuhrer et al., 2011) . A complete description of the technique used to perform nontargeted metabolic profiling can be found in Supplemental Experimental Procedures.
Statistics
To systematically individuate metabolites undergoing significant changes upon an antibiotic treatment, we used a regression analysis approach, in which each metabolite profile was fitted using adaptive regression splines (Friedman and Roosen, 1995) . The MATLAB package ARESLab was used. The quality of the fit was assessed by means of the sum of squared residuals (SSRs) and compared to the quality of fit to 1,000 random shuffling of the data time points. The underlying principle is that when intrinsic noise amplitude becomes comparable to the actual variance caused by the effect of an external perturbing agent, we expect the quality of the fitting of the real observed data to be comparable to random realization of the time course profiles. Hence, the statistical significance of changes observed for an individual metabolite was determined in terms of p values as the fraction of randomly permutated models with better fit (lower sum of squared residuals) than the original data.
To assess the similarity among individual metabolite profiles between drug pairs, we employed a dynamic time warping (DTW) algorithm to account for nonlinear delay in the metabolic response upon different antibiotics. Such difference in onset of response could be caused simply by higher or lower permeability of the membrane to the drugs or by a different dosage response. To this end, for each pair of antibiotics, the common affected ions are first normalized by their corresponding maximum change so that all metabolite profiles are within a [À1 1] interval. Individual metabolite profiles across the two compared conditions are aligned using DTW. DTW finds an optimal time warping (e.g., nonlinear time stretching) to superimpose one profile on the other. If the overlap between the metabolite changes in the two conditions (e.g., drug A versus drug B) was higher than 80%, we considered the metabolite to respond similarly to both external agents. Small changes of the 80% threshold used here do not qualitatively alter the results reported in Figure 1 . Those metabolites that show a similar response between a treated condition and the untreated-control conditions are filtered out from further analysis.
Growth Assay of Wild-Type and Gene-Knockout or GeneOverexpression Mutants under Norfloxacin, Nalidixic Acids, and Chloramphenicol All experiments to determine the MIC of wild-type E. coli or tested mutant strains were performed in microtiter plates. Cells were grown overnight in lysogeny broth (LB) medium. In the case of deletion mutant or overexpression constructs, the antibiotic for the respective selective markers (i.e., kanamycin and chloramphenicol) was added. Cultures were diluted 1:1,000 and reinoculated in the appropriate tested media (e.g., M9 medium plus casamino acids) at an initial optical density 600 (OD 600 ) of 0.05. To determine growth rates at different concentrations of chloramphenicol, trimethoprim, or sulfamethizole antibiotics, a microtiter plate reader (i.e., Tecan 200M) was used. Cells in the exponential growth phase were diluted to achieve an initial OD 600 of 0.05 in a total volume of 200 mL, and OD was recorded for 24 hr.
Gyrase Reporter Gene and Supercoiling Assay
To test GyrA activity, the E. coli DNA gyrase assay kit from TopoGEN was used. To monitor the gyrA promoter activity in untreated and treated E. coli cells, we used the reported gene assay developed in Anderle et al. (2008) . A complete description of the experimental procedures can be found in Supplemental Experimental Procedures.
ROS Assay
Intracellular ROS concentrations were measured using the dihydroethidium (DHE) assay, as described previously (Klinger et al., 2010) . See Supplemental Experimental Procedures for a detailed experimental protocol.
